Ipswich and East Suffolk CCG
North East Essex CCG
East Suffolk and North East Essex NHS Foundation Trust
Sub Chapters : 04 Central nervous system
- 5HT1 agonists
- 5HT3 antagonists
- Alcohol dependence
- Amantadine
- Analgesics
- Antihistamines
- Antimuscarinic drugs used in parkinsonism
- Anti-obesity drugs acting on the gastro-intestinal tract
- Antipsychotic depot injections
- Benzodiazepines
- Benzodiazepines
- Benzodiazepines
- Breakthrough pain
- Carbamazepine and Oxcarbazepine
- Catachol-O-methyltransferase inhibitors
- Chloral and derivatives
- CNS stimulants and other drugs used for attention deficit hyperactivity disorder
- Control of epilepsy
- Domperidone and metoclopramide
- Dopamine receptor agonists
- Dopaminergic drugs used in Parkinsons disease
- Drugs for dementia
- Drugs used in essential tremor, chorea, tics, and related disorders
- Drugs used in status epilepticus
- Ethosuximide
- First-Generation Antipsychotic Drugs
- Gabapentin and pregabalin
- Hyoscine
- Hypnotics
- Injectable
- Lacosamide
- Lamotrigine
- Levetiracetam
- Levodopa
- Lithium
- Mild to moderate dementia in Parkinsons disease
- Monoamine-oxidase inhibitors
- Monoamine-oxidase-B inhibitors
- Neurokinin receptor antagonist
- Neuropathic pain
- Nicotine dependence
- Non-opioid analgesics
- Opioid substitution therapy
- Opioid-receptor antagonists
- Other antidepressant drugs
- Other Drugs
- Other drugs for Ménière's disease
- Phenobarbital and other barbiturates
- Phenothiazines and related drugs
- Phenytoin
- Prophylaxis of migraine
- Related antidepressants
- Reverible MAOIs
- Second-Generation Antipsychotic Drugs
- Selective serotonin re-uptake inhibitors
- Strong opioids
- Tiagabine
- Topiramate
- Torsion dystonias and other involuntary movements
- Tricyclic antidepressants
- Valproate
- Valproic acid
- Vigabatrin
- Weak opioids
- Zaleplon, Zolpidem and Zopiclone
- Zonisamide